| 1.52 -0.09 (-5.59%) | 03-03 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
China Jo-Jo Drugstores, Inc., along with its subsidiary entities, functions as a prominent retailer and distributor of a wide array of pharmaceutical and healthcare products across the People's Republic of China. Its operations are structured into four distinct segments: retail pharmacies, an online drugstore, wholesale drug distribution, and the cultivation of medicinal herbs. The company's brick-and-mortar stores supply customers with diverse pharmaceutical items, including both prescription and over-the-counter medications, nutritional supplements, traditional Chinese remedies, personal and family care products, and medical devices. Beyond these, they also stock everyday convenience goods such as consumables, seasonal items, and promotional merchandise. To further enhance customer service, these locations feature licensed practitioners of both Western and Traditional Chinese Medicine, available at scheduled times for consultations, examinations, and the treatment of common ailments. Additionally, China Jo-Jo Drugstores operates an internet-based pharmacy, marketing over-the-counter medications and health supplements directly to consumers, as well as leveraging third-party e-commerce platforms for sales. The enterprise also engages in the wholesale supply of third-party pharmaceutical goods, primarily to trading companies, and manages the cultivation and distribution of herbs utilized in Traditional Chinese Medicine. As of March 31, 2021, the company maintained a network of 109 retail pharmacies operating under the 'Jiuzhou Grand Pharmacy' brand, supplemented by four other drugstores. Founded in 2003, the firm's corporate headquarters are situated in Hangzhou, People's Republic of China.
Mon, 14 Jul 2025
Ridgetech (RDGT) Stock Price, News & Analysis - MarketBeat
Thu, 24 Apr 2025
China Jo-Jo Drugstores (CJJD) Stock Price, News & Analysis - Stock Titan
Tue, 04 Feb 2025
China Jo-Jo Drugstores divests retail business to focus on wholesaling - Inside Retail Asia
Wed, 19 Apr 2023
China Jo-Jo Drugstores, CJJD, crashes 85% on disaster of a fundraise - Dhaka Tribune
Tue, 07 Feb 2023
China Jo-Jo Drugstores Inc. (Cayman Islands) (CJJD) - Value Research
Mon, 27 Jul 2015
Asia Practice - Pryor Cashman Represents China Jo-Jo Drugstores In Registered Direct Placement - Pryor Cashman LLP
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|